Although further prospective studies involving larger sample sizes are needed to validate the optimal monocytic MDSC graft dose that protects from acute GVHD, their results strongly suggested that the modulation of G-CSF may be used to affect M-MDSCs graft cell doses to prevent acute GVHD [25]. Here, CSF3 is linked to acute graft versus host disease.